Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Us Rrms Patient Preferences for Multiple Sclerosis Treatments: An Online Survey.
Herpes Simplex Virus-related Transverse Myelitis and Polyneuritis.
Autoimmune disease in people with multiple sclerosis and their relatives: a systematic review and meta-analysis.
Multiple sclerosis: Fatigue-a warning sign for multiple sclerosis?
[Teriflunomide for treatment of multiple sclerosis.]
Inhibition of endogenous phosphodiesterase 7 promotes oligodendrocyte precursor differentiation and survival.
Toward the comprehensive understanding of the gut ecosystem via metabolomics-based integrated omics approach.
Role of ERK1/2 MAPK Signaling in the Maintenance of Myelin and Axonal Integrity in the Adult CNS.
The roles of extracellular related-kinases 1 and 2 signaling in CNS myelination.
Pain in acquired inflammatory demyelinating polyneuropathies.
Graphene Functionalized Scaffolds Reduce the Inflammatory Response and Supports Endogenous Neuroblast Migration when Implanted in the Adult Brain.
Combining Double Fluorescence In Situ Hybridization with Immunolabelling for Detection of the Expression of Three Genes in Mouse Brain Sections.
Self-report assessment of fatigue in multiple sclerosis: a critical evaluation.
Medication withdrawal may be an option for a select group of patients in relapsing-remitting multiple sclerosis.
Clinical perspectives on medical marijuana (cannabis) for neurologic disorders.
B Cells Fuel Inflammation in Multiple Sclerosis.
Beclin 1 regulates neuronal transforming growth factor-β signaling by mediating recycling of the type I receptor ALK5.
The Plant-Derived Chalcone 2,2',5'-Trihydroxychalcone Provides Neuroprotection against Toll-Like Receptor 4 Triggered Inflammation in Microglia.
Microglia Plasticity During Health and Disease: An Immunological Perspective.
Duality of Antidepressants and Neuroprotectants.
Oxidative stress in multiple sclerosis: Central and peripheral mode of action.
Maturation and electrophysiological properties of human pluripotent stem cell-derived oligodendrocytes.
Clinical and economic impact of five-year adherence to disease-modifying therapies in a commercially insured multiple sclerosis population.
Elderly-onset neuromyelitis optica spectrum disorders.
Conclusion: National incidence and risk factor assessments may become a basis for the evaluation of prevention trials - prospects from the Third Nordic MS Symposium.

Pages